NCT05994300 - Moderately Hypofractionated Adaptive Radiotherapy for Cervical Cancer | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 19, 2023

Primary Completion Date

July 22, 2024

Study Completion Date

December 31, 2025

Conditions

Cervical NeoplasmAdaptive RadiotherapyRadiotherapy; Adverse Effect

Interventions

RADIATION

Moderately hypofractionated adaptive radiotherapy (ART)+ High-dose rate (HDR) Brachytherapy

"Experimental: 43.35Gy/17F external beam radiotherapy (EBRT) with adaptive radiotherapy (ART) + HDR-Brachytherapy~Drug: Concurrent Chemotherapy~Weekly cisplatin 40 mg/m2"

Trial Locations (1)

100010

Peking Union Medical College Hospital, Beijing

All Listed Sponsors

lead

Peking Union Medical College Hospital

OTHER